| Literature DB >> 3280080 |
Abstract
In a prospective randomised study the effect of flutamide 750 mg daily was compared with that of stilboestrol 3 mg daily in the treatment of 40 previously untreated patients with advanced prostatic cancer. There was a good subjective response to both treatments. After 12 months, a response was demonstrated in 13 of 20 patients treated with flutamide and 8 of 20 patients treated with stilboestrol. The difference was not statistically significant. Treatment with stilboestrol caused more frequent, and more severe, side effects than flutamide.Entities:
Mesh：
Substances：
Year: 1988 PMID： 3280080 DOI： 10.1111/j.1464-410x.1988.tb05062.x
Source DB: PubMed Journal: Br J Urol ISSN： 0007-1331